Pill Imprint CE 139
This orange capsule-shape pill with imprint CE 139 on it has been identified as: Imatinib 400 mg.
This medicine is known as imatinib. It is available as a prescription only medicine and is commonly used for Acute Lymphoblastic Leukemia, Chronic Eosinophilic Leukemia, Chronic Myelogenous Leukemia, Dermatofibrosarcoma Protuberans, Gastrointestinal Stromal Tumor, Hypereosinophilic Syndrome, Myelodysplastic Diseases, Myeloproliferative Disorders, Systemic Mastocytosis.
Details for pill imprint CE 139
- Drug
- Imatinib
- Imprint
- CE 139
- Strength
- 400 mg
- Color
- Orange
- Shape
- Capsule-shape
- Availability
- Prescription only
Pill Classification
- National Drug Code (NDC)
- 621350659
Read this next
-
Is A Universal Cancer Treatment On The Horizon?
The discovery of a new type of T cell could lead to the development of a therapy that may treat all cancers
-
Leukemia vs. Lymphoma: What’s the Difference?
Both diseases are blood cancers, but leukemia is found in the blood and bone marrow while lymphoma appears in the lymph nodes
-
Leukemia: Understanding the Basics
Leukemia is a type of blood cancer that interferes with the body’s ability to produce normal types of white blood cells
-
Stages of Leukemia: What You Should Know
During a diagnosis of leukemia, one of the most important determinations a doctor makes is the stage, which describes the degree and seriousness of the cancer
